APA (7th ed.) Citation

AW, K., M, A., KC, S., JP, C., TJ, B., A, D., . . . KA, J. (2026). Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: A translational study. Cardiovascular diabetology, 25(1), 61. https://doi.org/10.1186/s12933-025-03060-5

Chicago Style (17th ed.) Citation

AW, Khan, et al. "Activator Protein-1 (AP-1) Inhibition Prevents Endothelial to Mesenchymal Transition in Diabetes-associated Atherosclerosis: A Translational Study." Cardiovascular Diabetology 25, no. 1 (2026): 61. https://doi.org/10.1186/s12933-025-03060-5.

MLA (9th ed.) Citation

AW, Khan, et al. "Activator Protein-1 (AP-1) Inhibition Prevents Endothelial to Mesenchymal Transition in Diabetes-associated Atherosclerosis: A Translational Study." Cardiovascular Diabetology, vol. 25, no. 1, 2026, p. 61, https://doi.org/10.1186/s12933-025-03060-5.